Evidence map›Paper›PMID 21347118›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2010

Facilitating Clinical Research through the Health Information Exchange: Lipid Control as an Example.

Vivienne J Zhu, Wanzhu Tu, Marc B Rosenman, J Marc Overhage

Open access · greenAbstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Vivienne J ZhuRegenstrief Institute and.
Wanzhu Tu
Marc B Rosenman
J Marc Overhage
Regenstrief Institute · US

Funding

REGENSTRIEF MEDICAL INFORMATICS RESEARCH FELLOWSHIPST15LM007117 · NLM · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI FINNELL, JOHN T · 1997 to 2011
$5.0M
AHRQ HHS T32 HS017588NLM NIH HHS T15 LM007117
6 · The paper itself

Abstract

Using data from the Indiana Network of Patient Care (INPC), we analyzed long-term statin adherence patterns and their effects on low-density lipoprotein cholesterol (LDL-C) control among patients with type 2 diabetes. Statin adherence was measured by proportion of days covered (PDC) for a 6-month interval prior to each LDL-C test date. Patient demographic and clinical characteristics were used as covariates for LDL-C control and predictors for statin adherence. From 4,350 eligible subjects, 25,596 6-month PDC and LDL-C level pairs were formed between 2001 and 2009. Rates of suboptimal adherence and suboptimal LDL-C control were 68.5% and 46.6%, respectively. Positive predictors for LDL-C control included adherence to statin (OR: 1.87, p<0.0001) and older age (OR: 1.11, p=0.01). Significant risk factors for non-adherence were young age, female gender, African American race and newly-treated status. This study demonstrated the utility of a health information exchange in health outcome and clinical effectiveness research.

Indexed as

Diabetes Mellitus, Type 2Health Information ExchangeCholesterol, LDLHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsLipids

Identifiers

PMID21347118
PMCPMC3041406
OpenAlexW1488838134

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.